NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.46% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.34% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 2.23% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.21% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.15% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.04% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.02% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 1.97% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 1.97% |
| TBPH | Theravance Biopharma Inc | Healthcare | Biotechnology | 1.96% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 1.95% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.95% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.93% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.93% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 1.92% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.91% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.91% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 1.90% |